Upcoming Conference
Salt Lake City, Utah, April 26, 2023

5 Things California: May Revise, Abortion protections, Statewide HIE preparedness

| May 19, 2022 | California

We've got some important updates in this week's newsletter, including several on-the-move bills and an overview of health funding in Gov. Newsom's May Revise budget proposal. We also have coverage of the steps California is taking to protect abortion rights in the wake of a likely Roe v. Wade overturn, and...[ Read More ]

Effort to require health plans to share PBM rebate savings with enrollees moves forward in California Legislature

| May 10, 2022 | California

California legislators are considering a bill that aims to make the cost-savings from rebates negotiated between pharmacy benefit managers (PBMs) and prescription drug manufacturers directly available to consumers at the point of sale.  Sponsored by Sen. Sydney Kamlager (D - Los Angeles), SB 1361 would require a health plan enrollee’s...[ Read More ]

Pharmacy industry voices opposition to California's effort to prohibit discriminatory PBM practices

| Apr 4, 2022 | California

Sen. Richard Pan (D-Sacramento) is sponsoring a bill that would prevent pharmacy benefit managers (PBMs) from discriminating against 340B-covered entities for which they’re statutorily required to provide discounted prescription drugs. While the Senate Health Committee recently voted to advance the bill, pushing it closer to a full Senate floor vote,...[ Read More ]

Lawmakers work to protect 340B entities from PBM practices

| Mar 3, 2022 | Colorado

Supporters of a bipartisan initiative in Colorado to restrict discriminatory pharmacy benefit manager (PBM) practices say the contracting practices of PBMs and other third-party payers is reducing medication access for 340B-covered patients. House Bill 1122, sponsored by Rep. Perry Will (R - New Castle), would prohibit PBMs from reimbursing a...[ Read More ]

5 Slides We're Discussing: The policy implications of new medicines

| Nov 17, 2021 | Illinois, Michigan

Panelists discussed the importance of transparency and need for cost reductions on specialty drugs in State of Reform’s recent virtual conversation “5 Slides We’re Discussing: The policy implications of new medicines.”  The experts called on pharmaceutical companies and pharmacy benefit managers (PBMs) to be more transparent in their pricing and...[ Read More ]

Texas drug-pricing transparency bill passes full Legislature

Sara Gentzler | May 24, 2019 | Texas

A drug-pricing transparency bill that aims to establish reporting requirements for pharmaceutical drug manufacturers, health plans, and pharmacy benefit managers passed the full Texas Legislature this week. The House of Representatives concurred with Senate amendments to HB 2536 on Friday -- now, it awaits signatures from both presiding officers and...[ Read More ]